Home > Boards > US OTC > Medical - Equipment >

Imris Inc. (IMRSQ)

Add IMRSQ Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 12/17/2018 9:46:48 AM - Followers: 17 - Board type: Free - Posts Today: 0

IMRIS provides fully integrated image guided therapy solutions that deliver timely information to clinicians for use during surgical or interventional procedures. Our solutions incorporate magnetic resonance imaging and fluoroscopy into multi purpose surgical suites for specific medical applications. Our products are sold globally to hospitals that deliver clinical services to patients in the neurosurgical, interventional neurovascular and cardiovascular markets.

Patients: The patient does not need to be moved for imaging during the course of a surgical or interventional procedure with IMRIS systems. This saves time and avoids potential safety risks associated with moving the patient.

Clinicians: IMRIS systems are designed to enhance the workflow of the clinical team. High resolution imaging information is available rapidly and presented in a manner designed to enhance clinician efficiency and effectiveness. In addition, since the patient is not moved for imaging, the patient can be maintained in the optimal position and clinicians are afforded unrestricted access to the patient.

Hospitals: The IMRIS suite design permits greater utilization of the MR equipment by allowing the MR scanner to be shared by one or more clinical suites and an adjacent diagnostic room.

Our mission is to provide image guided therapy solutions that enhance the quality of clinical procedures and improve outcomes for patients. Through our ongoing investment in research and development we are committed to broadening our product portfolio with solutions to address additional medical applications.


The Management Team

DAVID GRAVES, Chairman, and Chief Executive Officer

David Graves

Mr. Graves is the Chief Executive Officer and the Chairman of the board of directors. He has been Chief Executive Officer since the formation of the corporation in May 2005. From 1998 until 2005, Mr. Graves was the President and Chief Executive Officer of Centara Corporation, a venture capital firm. Prior to that, he was the founder and Chief Executive Officer of Broadband Networks Inc., a leading-edge developer of wireless telecommunications systems. Mr. Graves is a graduate of the University of Manitoba faculty of Engineering and the Executive Marketing program at Queen's University and is a registered professional engineer. Mr. Graves serves on the board of directors of Great West Lifeco. Inc.

KELLY MCNEILL, Executive Vice President, Finance and Administration and Chief Financial Officer

Kelly McNeill

Mr. McNeill is a Chartered Accountant with several years of experience and expertise across all areas of corporate finance and operations. He has held leadership positions with companies in both the biotechnology and manufacturing sectors. Most recently Mr. McNeill served as Chief Financial Officer with Resverlogix Corp., a publicly traded biotechnology company based in Canada.

Mr. McNeill is a member of the Institute of Chartered Accountants of Alberta and holds a Masters of Accountancy and Bachelor of Commerce (Honours) from the University of Manitoba.

DENIS SUTTON, Executive Vice President, Human Resources

Denis Sutton

Mr. Sutton joined IMRIS as Executive Vice President, Human Resources in March 2007, bringing more than 30 years of human resource management experience. Mr. Sutton was Senior Vice President of MTS Allstream from 2005 to 2007. Prior to that he was Chief Human Resources Officer for St. Boniface General Hospital. Mr. Sutton is a management member of the Manitoba Labour Board and the Council of Human Resource Executives for the Conference Board of Canada.

MARK READE, Executive Vice President, Global Sales

Mark Reade

Mr. Reade joined IMRIS in 2010 as Executive Vice President, Customer Solutions and was appointed Executive Vice President, Global Sales in 2011. Prior to joining IMRIS, he was with Medtronic, both in Canada and the United States where his most recent role was that of Vice President (South East Region) of Medtronic Neuromodulation. A graduate of McGill University in Commerce and Economics and with an MBA from the Ivey School of Business at the University of Western Ontario, Mr. Reade's 20+ year career in the medical device industry has included management positions at Superior Healthcare Group; Howmedica (Pfizer); and, Baxter Corporation.

AMY BOYLE, Executive Vice President, Marketing

Ms. Boyle joined IMRIS in 2010 as Executive Vice President Marketing and is responsible for the Company's upstream and downstream marketing initiatives, product management, sales support programs and emerging market development. She has 17 years of senior sales and marketing experience with Medtronic and prior to joining IMRIS, held senior positions with St. Jude Medical where her most recent role was Vice President Corporate Brand and Marketing.

Ms. Boyle holds a Bachelor of Science degree from Queen's University and an MBA from the Schulich School of Business at York University.

MEIR DAHAN, Executive Vice President, Research and Development

In his leadership role as EVP of R&D, Meir Dahan draws on an outstanding record in the development of high-quality innovations and an unwavering commitment to customer satisfaction. During more than 16 years of diverse product-development experience, Meir devoted 10 years to fast-paced, rapidly expanding telecommunications segments and, most recently, spent more than 6 years in medical-device product development.

He brings to IMRIS an extensive background in the design, development and launch of commercial product platforms with Baxter Healthcare, 3Com Corporation and US Robotics.

Meir holds an MBA and an MS of Electrical Engineering from the Illinois Institute of Technology in Chicago and a BSEE from Ben Gurion University in Israel.

PABLO BATISTA, Executive Vice President, Operations

Pablo Batista joined IMRIS in February 2007 as Vice President, Production and was promoted to Executive Vice President, Operations in January, 2009. He is responsible for all aspects of manufacturing and supply chain, quality assurance , regulatory affairs and information technology.

Prior to joining IMRIS, Mr. Batista was a Senior Program Manager with New Flyer Industries where he led numerous cross functional teams responsible for new product development. He was also Executive Director, Plant Operations for Motor Coach Industries managing a North American, multi-location business.

Mr. Batista holds a B.Sc in Mechanical Engineering from La Salle University in Mexico City and has over 25 years of industrial manufacturing experience in Canada the USA and Mexico.

HARTMUT WARNKEN, Vice President & General Manager, Europe


Mr. Warnken joined IMRIS as Director Customer Solutions for Europe and Middle East in August 2009 and was appointed as Vice President & General Manager, Europe & Middle East in January 2010. Previously, Mr. Warnken worked at BrainLAB as Senior Technical Consultant and Director for the intra-operative operating room solutions division. Prior to that he was Lead Architect for an architectural firm in Germany. 

Mr. Warnken holds a degree in Architecture, a Masters of Engineering and an MBA from the European Business School ESCP EUROPE.

KE NING, Vice President & General Manager, China

Ke Ning

Mr. Ning joined IMRIS in 2010 as Vice President & General Manager, China. Mr. Ning began his career as a radiologist at Beijing's Children's Hospital and since then he has held key roles as Global Marketing Manager and General Manager at Agilent Technologies and GE Healthcare. Prior to joining IMRIS, he was General Manager, DXR Modality for Greater China at GE Healthcare. 

Mr. Ning holds a Bachelors Degree in Medical Imaging from China Medical University.

Investor Contact

Brad Woods
Phone: 204.480.7094
Email: bwoods@imris.com

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#554   IMRSQ SEC Suspension "because of questions regarding the Renee 12/17/18 09:46:48 AM
#553   Some buying volume here during the last weeks... Klinsmann 02/23/18 03:39:39 PM
#552   Everyone gone? shanak10 11/27/17 12:13:20 PM
#551   IMRSQ-WHOOO HOOOOO!! BettingAngles 01/05/16 11:37:37 AM
#550   good posibility it may go too...heve a little buccaneer1961 09/09/15 09:52:17 PM
#549   What do you think? BONGO68 09/09/15 09:49:37 PM
#548   ok,good idea buccaneer1961 09/09/15 09:32:26 PM
#547   I think it will do a little run BONGO68 09/09/15 11:52:16 AM
#546   whats your thoughts on this? buccaneer1961 09/09/15 11:29:02 AM
#545   http://www.marketwatch.com/story/intraoperative-imaging-market-by-type-by-geogra BONGO68 09/01/15 02:51:30 PM
#544   I hope so....bun what catalyst? buccaneer1961 08/25/15 12:25:37 AM
#543   So with insiders still holding 1/3 of the BONGO68 08/24/15 10:36:03 AM
#542   so...will it remain public afterall? buccaneer1961 08/18/15 11:18:07 AM
#541   DJ Deerfield Scoops Up IMRIS from Bankruptcy -- OTCRIDER 08/14/15 10:16:49 PM
#540   12. august was yesterday and ...? Weisloom 08/13/15 02:24:55 AM
#539   Bad IMRIS and Neuroarm operating reports of June frankie65 07/30/15 04:58:40 AM
#537   Other NASDAQ delist sample is YUII was Delisted $$$TOCK 007 07/29/15 10:37:49 AM
#536   I figured the form 25 was only for SukhshantiOm 07/28/15 02:01:43 PM
#535   It seems that today IMRSQ has not been traded. frankie65 07/27/15 03:14:34 PM
#534   25-NSE may NOT problem at all , NYSE $$$TOCK 007 07/24/15 10:01:14 PM
#532   you actually may be right modrica 07/24/15 08:20:32 PM
#530   imris has been trading on otc pink for modrica 07/24/15 05:28:02 PM
#529   But imris will still traded on otc pink market. frankie65 07/24/15 03:40:49 PM
#528   it appears that there was no other bids modrica 07/24/15 03:21:24 PM
#527   Today Imris was bought by Deerfield. frankie65 07/24/15 03:08:12 PM
#526   they were already moved from nasdaq and been modrica 07/23/15 08:17:01 PM
#524   It says they are de-registering from NASDAQ, it SukhshantiOm 07/23/15 03:58:32 PM
#523   notification of removal from listing filed - 25-nse modrica 07/23/15 03:35:55 PM
#522   well of course , otherwise wouldn't be bk modrica 07/22/15 09:39:33 AM
#521   Wrong!!!!!! This is a pos... posilock 07/21/15 08:42:56 PM
#519   Smoke and Mirrors BONGO68 07/20/15 11:46:44 AM
#518   Ouch! Sure am glad I didn't buy back posilock 07/20/15 10:31:12 AM
#517   bid deadline was today and considering pps increase modrica 07/17/15 05:40:58 PM
#516   There's no way to predict the Bottom of VST7 07/17/15 02:39:11 PM
#515   Exactly - lol DukeSilver 07/17/15 02:10:22 PM
#514   No offense, but you called this play on SukhshantiOm 07/17/15 02:07:14 PM
#513   $IMRSQ now up 40% - another Big Winner!! ospreyeye 07/17/15 01:56:35 PM
#512   $IMRSQ Chart - Very sweet follow through today ospreyeye 07/17/15 01:24:27 PM
#511   nice, looks like we may have some good SukhshantiOm 07/17/15 01:15:33 PM
#510   Let's see how the stock will move today. frankie65 07/17/15 07:00:07 AM
#509   Just read through the "Bidding Procedures Order" and IEMAREIS 07/17/15 06:17:36 AM
#508   None of IMRIS’s other operating subsidiaries outside of modrica 07/16/15 06:21:58 PM
#507   meeting of creditors was yesterday so it appears modrica 07/16/15 03:52:16 PM
#506   tomorrow ? modrica 07/15/15 09:02:01 PM
#505   That means this thing is worthless tomorrow DukeSilver 07/15/15 06:11:19 PM
#504   yes.. Darrell, There will be an auction for the company buccaneer1961 07/15/15 04:11:04 PM
#503   Buc - did you hear back from anyone? DukeSilver 07/15/15 03:50:18 PM
#502   next week bidding procedure starts modrica 07/15/15 03:46:29 PM
#501   lots of volume coming in and bid is SukhshantiOm 07/15/15 02:28:43 PM
#500   tomorrow 10.00 AM est is meeting of creditors modrica 07/14/15 09:33:24 AM
Consent Preferences